Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis

BACKGROUND AND AIMS: Previous meta-analyses have shown that aspirin use may reduce the risk of hepatocellular carcinoma (HCC). However, the optimal dose, frequency, and duration of aspirin use or the safety and efficacy of aspirin in target populations for HCC prevention remain unclear. The study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lun-Jie, Yao, Sheng-Yu, Li, Hai-Chao, Meng, Guang-Xiao, Liu, Kai-Xuan, Ding, Zi-Niu, Hong, Jian-Guo, Chen, Zhi-Qiang, Dong, Zhao-Ru, Li, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547262/
https://www.ncbi.nlm.nih.gov/pubmed/36304506
http://dx.doi.org/10.14218/JCTH.2021.00257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547262/
https://www.ncbi.nlm.nih.gov/pubmed/36304506
http://dx.doi.org/10.14218/JCTH.2021.00257

Ejemplares similares